Skip to content
MedsAcross

Medicine

Dorzolamide 20 mg/mL ophthalmic solution

Dorzolamide · Ophthalmic
Available on requestPrescription onlyUS FDAGeneric name

Dorzolamide 20 mg/mL ophthalmic solution is a generic prescription medicine for ophthalmic use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 15°C to 30°C (59°F to 86°F). Protect from light.

Key facts

Active ingredient (INN)
Dorzolamide
Brand
Sold under the generic name
Strength
20 mg/mL
Dosage form
Ophthalmic solution
Route
Ophthalmic
Packs
1 bottle, 10 mL and 3 more
Manufacturers
Gland PharmaIndiaLeading PharmaAdvagen PharmaFlorida Pharmaceutical ProductsFosun Pharma
Origin register
US FDA, United States
Storage
Store at 15°C to 30°C (59°F to 86°F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
S01EC03 Dorzolamide
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 December 2019
Identifiers
RxCUI 310015DailyMed set ID ef173b63-499f-301b-e053-2995a90a4771, 2023e603-12bb-4502-9f93-0126e0cc24ed, ed9d1658-43cc-4c78-b3d8-e7d980a6b673 +2NDC 72266-197, 68083-489, 72888-077 +2Application ANDA215660, ANDA078395, ANDA202053 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 bottle in 1 carton / 10 mL in 1 bottle68083-489-01Gland PharmaIndia27 January 2022
1 bottle in 1 carton / 10 mL in 1 bottle72888-077-15Advagen Pharma23 December 2024
10 mL in 1 bottle71921-400-10Florida Pharmaceutical Products7 May 2025
1 bottle in 1 carton / 10 mL in 1 bottle72266-197-01Fosun Pharma23 January 2023
1 bottle in 1 carton / 5 mL in 1 bottle69315-304-05Leading Pharma1 December 2019
1 bottle in 1 carton / 10 mL in 1 bottle69315-304-10Leading Pharma1 December 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 9 December 1994Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Dorzolamide

Clinical summary

Dorzolamide is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. It is available as eye drops and ophthalmic solution. MedsAcross supplies Dorzolamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Dorzolamide

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Dorzolamide 20 mg/mL ophthalmic solution for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.